Over-the-counter medication · Corticosteroid
fluticasone
Also sold as Flonase, Flovent. Fluticasone temporarily relieves symptoms of hay fever or other upper respiratory allergies.
Data updated 2026-05-15
- 46,155
- FDA reports
- 7
- InteractionsFew interactions
- 89% less
- Generic vs brandHuge savings
- In shortage
- FDA status
What the data shows
fluticasone (Flonase) is an over-the-counter Corticosteroid, with 46,155 FDA adverse-event reports on file, whose generic runs roughly half the brand price or less (89% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
fluticasone (Flonase) is an over-the-counter Corticosteroid. Fluticasone temporarily relieves symptoms of hay fever or other upper respiratory allergies.
Fluticasone is a steroid medicine that helps reduce inflammation in your nose. It can help relieve allergy symptoms.
Verify with FDA → · CMS NADAC pricing →
Drug Shortage Alert
fluticasone is currently listed as to be discontinued by the FDA. Affected manufacturer: Teva Pharmaceuticals USA, Inc..
View all drug shortages →Drug Pricing (NADAC)
Brand Price
$3.27/unit
Generic Price
$0.37/unit
Generic Savings
89%
Generic Available
Yes (21 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Fluticasone temporarily relieves symptoms of hay fever or other upper respiratory allergies.
Common side effects
Headache, Fatigue
Key warnings
Children 4 to 11 years of age: The growth rate of some children may be slower while using this product.
The sections below are summarized in plain English from fluticasone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Fluticasone is a corticosteroid. It works by reducing inflammation in the nasal passages. This helps to relieve allergy symptoms.
Side Effects (from patient reports)
Based on 46,155 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for fluticasone, by number of reports
- Headache
Headache
6,061 reports
- Tiredness
Tiredness
5,935 reports
- Difficulty breathing
Difficulty breathing
5,830 reports
- Feeling sick to your stomach
Feeling sick to your stomach
5,209 reports
- Pain
Pain
4,528 reports
- Diarrhea
Diarrhea
4,382 reports
- Cough
Cough
4,088 reports
- Feeling dizzy
Feeling dizzy
3,914 reports
- Pneumonia
Pneumonia
3,208 reports
- Asthma
Asthma
3,000 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Serious Warnings
Children 4 to 11 years of age: The growth rate of some children may be slower while using this product. Children should use it for the shortest time needed to relieve symptoms. Talk to your child’s doctor if they need to use the spray for longer than two months a year.
Known Drug Interactions
betamethasone budesonide ciclesonide fluticasone methylprednisolone mometasone triamcinolone ↑ corticosteroids Co-administration with corticosteroids (all routes of administration) of which exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing's syndrome and adrenal suppression.
Mechanism: Darunavir blocks the body from breaking down fluticasone, which can lead to very high steroid levels in your blood. This can cause serious hormone problems like Cushing's syndrome.
Corticosteroids primarily metabolized by CYP3A betamethasone, budesonide, ciclesonide, dexamethasone, fluticasone, methylprednisolone, mometasone, triamcinolone ↑ corticosteroid Co-administration with corticosteroids (all routes of administration) of which exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing’s syndrome and adrenal suppression.
Mechanism: This medication prevents your body from clearing the steroid fluticasone. This can lead to very high steroid levels, which may cause serious issues with your body's natural hormone production.
( 7.4 ) 7.1 Inhibitors of Cytochrome P450 3A4 Fluticasone propionate and salmeterol, the individual components of ADVAIR DISKUS, are substrates of CYP3A4. Ritonavir Fluticasone Propionate: A drug interaction trial with fluticasone propionate aqueous nasal spray in healthy subjects has shown that ritonavir (a strong CYP3A4 inhibitor) can significantly increase plasma fluticasone propionate exposure, resulting in significantly reduced serum cortisol concentrations [see Clinical Pharmacology ( 12.3 )] . During postmarketing use, there have been reports of clinically significant drug...
Mechanism: Both of these products contain the same steroid medicine. Taking them together increases the amount of medicine in your body, which can lower your natural hormone levels.
( 7.5 ) 7.1 Inhibitors of Cytochrome P450 3A4 Fluticasone furoate and vilanterol are substrates of CYP3A4. Concomitant administration of the strong CYP3A4 inhibitor ketoconazole increases the systemic exposure to fluticasone furoate and vilanterol.
Mechanism: Both of these medications contain the same steroid ingredient. Taking them together increases the total amount of medicine in your body, which can lead to more side effects.
( 7.4 ) 7.1 Inhibitors of Cytochrome P450 3A4 Fluticasone furoate and vilanterol are both substrates of CYP3A4. Concomitant administration of the strong CYP3A4 inhibitor ketoconazole increases the systemic exposure to fluticasone furoate and vilanterol.
Mechanism: These two medications contain the same active steroid. Using them at the same time can cause the drug levels to build up too high in your system.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
How often should I use this?
Can children use this medicine?
How many sprays should I use?
What should I do if my child needs to use this for a long time?
Do I need to do anything special before using the spray?
What if this medicine doesn't seem to be working?
Can I use more than the recommended dose to get better faster?
Where should I keep this medicine?
What if I miss a dose?
Is this safe to use during pregnancy?
What are the common side effects of fluticasone?
Does fluticasone interact with other medications?
What drug class is fluticasone?
Is there a generic version of fluticasone?
What pregnancy or breastfeeding source fields are listed for fluticasone?
Has fluticasone been recalled?
Is fluticasone currently in shortage?
Active Recalls
CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
Golden State Medical Supply Inc.
Related Medications in Corticosteroid
Other drugs grouped near fluticasone - same-class peers and common alternatives.
azelastine
Astelin, Astepro
Azelastine nasal spray is an antihistamine medicine.
Compare with fluticasone →
budesonide nasal
Rhinocort
Rhinocort is a nasal spray that helps relieve allergy symptoms.
Compare with fluticasone →
cetirizine
Zyrtec
Cetirizine (Zyrtec) is an antihistamine medicine.
Compare with fluticasone →
chlorpheniramine
Chlor-Trimeton
Chlorpheniramine is an antihistamine medicine.
Compare with fluticasone →
ciclesonide nasal
Omnaris, Zetonna
Omnaris Nasal Spray is a medicine that helps treat allergy symptoms in your nose.
Compare with fluticasone →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Pain Relievers Compared
NSAIDs vs acetaminophen, which OTC pain reliever to use
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
What the FDA Data Shows for fluticasone
The FDA label for fluticasone (sold under brand names such as Flonase, Flovent) classifies it as an over-the-counter product in the Corticosteroid class. Fluticasone temporarily relieves symptoms of hay fever or other upper respiratory allergies. Official labeling lists 2 commonly reported side effects, including Headache, Fatigue.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 46,155 voluntary reports. The database also lists 7 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.37 versus $3.27 for the brand - a 89% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 1 recall record on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: February 4, 2026
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages